Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma
2024-519066-49-01Phase 4Authorised
- Sponsor
- Capital Region of Denmark
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bleomycin in basal cell carcinoma (BCC) (2 arms), sponsored by Capital Region of Denmark. Planned start Dec 2024; status: authorised.
02
Drugs
bleomycin
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2024-519066-49-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519066-49-01.